Literature DB >> 19672147

The clinical experience with particle therapy in adults.

Daniela Schulz-Ertner1.   

Abstract

Radiation therapy with charged particles, such as protons and heavier ions, provides physical selectivity and therefore allows for favorable dose distributions in comparison with conventional photon radiotherapy. Carbon ions furthermore exhibit biologic advantages related to their high linear energy transfer properties in a number of tumors known to be relatively insensitive to low-linear energy transfer radiation therapy. Over the last 2 decades, major developments in the fields of accelerator technology, diagnostic techniques, and beam delivery methods have been made. These developments formed the basis for the application of particle beams in clinical surroundings. Many clinical centers are already considering the introduction of radiation therapy with charged particles. This article reviews the clinical experience with particle therapy in adults available so far.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19672147     DOI: 10.1097/PPO.0b013e3181b01922

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  9 in total

1.  ENLIGHT and other EU-funded projects in hadron therapy.

Authors:  M Dosanjh; B Jones; R Mayer; R Meyer
Journal:  Br J Radiol       Date:  2010-10       Impact factor: 3.039

2.  Chromosome aberration measurements in mitotic and G2-PCC lymphocytes at the standard sampling time of 48 h underestimate the effectiveness of high-LET particles.

Authors:  Ryonfa Lee; Elena Nasonova; Carola Hartel; Marco Durante; Sylvia Ritter
Journal:  Radiat Environ Biophys       Date:  2011-04-11       Impact factor: 1.925

Review 3.  The potential benefit of radiotherapy with protons in head and neck cancer with respect to normal tissue sparing: a systematic review of literature.

Authors:  Tara A van de Water; Hendrik P Bijl; Cornelis Schilstra; Madelon Pijls-Johannesma; Johannes A Langendijk
Journal:  Oncologist       Date:  2011-02-24

4.  Apoptosis and expression of apoptosis-related genes in mouse intestinal tissue after whole-body proton exposure.

Authors:  Ashley Purgason; Ye Zhang; Stanley R Hamilton; Daila S Gridley; Ayodotun Sodipe; Olufisayo Jejelowo; Govindarajan T Ramesh; Maria Moreno-Villanueva; Honglu Wu
Journal:  Mol Cell Biochem       Date:  2017-11-02       Impact factor: 3.396

Review 5.  Clinical trials involving carbon-ion radiation therapy and the path forward.

Authors:  Ann A Lazar; Reinhard Schulte; Bruce Faddegon; Eleanor A Blakely; Mack Roach
Journal:  Cancer       Date:  2018-10-11       Impact factor: 6.860

6.  Autophagy prevents irradiation injury and maintains stemness through decreasing ROS generation in mesenchymal stem cells.

Authors:  J Hou; Z-p Han; Y-y Jing; X Yang; S-s Zhang; K Sun; C Hao; Y Meng; F-h Yu; X-q Liu; Y-f Shi; M-c Wu; L Zhang; L-x Wei
Journal:  Cell Death Dis       Date:  2013-10-10       Impact factor: 8.469

7.  The efficacy of human placenta-derived mesenchymal stem cells on radiation enteropathy along with proteomic biomarkers predicting a favorable response.

Authors:  Young-Min Han; Jong-Min Park; Yong Soo Choi; Hee Jin; Yun-Sil Lee; Na-Young Han; Hookeun Lee; Ki Baik Hahm
Journal:  Stem Cell Res Ther       Date:  2017-05-02       Impact factor: 6.832

8.  Phase I study evaluating the treatment of patients with locally advanced pancreatic cancer with carbon ion radiotherapy: the PHOENIX-01 trial.

Authors:  Stephanie E Combs; Daniel Habermehl; Meinhard Kieser; Constantin Dreher; Jens Werner; Renate Haselmann; Oliver Jäkel; Dirk Jäger; Markus W Büchler; Jürgen Debus
Journal:  BMC Cancer       Date:  2013-09-14       Impact factor: 4.430

Review 9.  Proton therapy- the modality of choice for future radiation therapy management of Prostate Cancer?

Authors:  Sophie Mangan; Michelle Leech
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2019-10-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.